Max Salfinger

8.5k citations

113 papers · 5.7k indexed · 2 hit papers · h-index 38

Impact in

Infectious Diseases top 0.2%
- Tuberculosis Research and Epidemiology
Epidemiology top 0.5%
- Mycobacterium research and diagnosis
- Pneumocystis jirovecii pneumonia detection and treatment
- Pneumonia and Respiratory Infections

Papers in ⓘ

Infectious Diseases 76
- Tuberculosis Research and Epidemiology 73
Epidemiology 94
- Mycobacterium research and diagnosis 87
- Pneumocystis jirovecii pneumonia detection and treatment 7
- Pneumonia and Respiratory Infections 6

Co-authors: Linda M. Parsons (17 shared papers)Ákos Somoskövi (22 shared papers)David M. Warshauer (4 shared papers)Tawanda Gumbo (2 shared papers)Mark R. Deziel (2 shared papers)Arnold Louie (2 shared papers)Gerald H. Mazurek (3 shared papers)Charles L. Daley (6 shared papers)
Journals: Journal of Clinical Microbiology (21 papers)Clinical Infectious Diseases (7 papers)Diagnostic Microbiology and Infectious Disease (4 papers)European Journal of Clinical Microbiology & Infectious Diseases (4 papers)Antimicrobial Agents and Chemotherapy (4 papers)
Partner nations: United States Switzerland Hungary

In The Last Decade

Max Salfinger

110 papers receiving 5.5k citations

Hit Papers

align trajectories log scale

Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children 2017 · 476 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 Clinical Infectious Diseases
2016 Clinical Infectious Diseases

Peers

Countries citing papers authored by Max Salfinger

Since Specialization

Citations

This map shows the geographic impact of Max Salfinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Salfinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Salfinger more than expected).

Fields of papers citing papers by Max Salfinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Salfinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Salfinger. The network helps show where Max Salfinger may publish in the future.

Co-authors

The 25 scholars most cited alongside Max Salfinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Max Salfinger Line = papers co-authored together Max Salfinger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 113 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children Clinical Infectious Diseases ·David Lewinsohn, Michael Leonard, Philip LoBue, David L. Cohn, Charles L. Daley, Ed Desmond, Joseph Keane, Ann M. Loeffler, Gerald H. Mazurek, Richard O’Brien, Madhukar Pai, Luca Richeldi, Max Salfinger, Thomas M. Shinnick, Timothy R. Sterling, David M. Warshauer, Gail L. Woods Hit paper breakdown →	2016	656
2	Official American Thoracic Society/Infectious Diseases Society of America/Centers for Disease Control and Prevention Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children Clinical Infectious Diseases ·David Lewinsohn, Michael Leonard, Philip LoBue, David L. Cohn, Charles L. Daley, Ed Desmond, Joseph Keane, Ann M. Loeffler, Gerald H. Mazurek, Richard O’Brien, Madhukar Pai, Luca Richeldi, Max Salfinger, Thomas M. Shinnick, Timothy R. Sterling, David M. Warshauer, Gail L. Woods Hit paper breakdown →	2017	476
3	Concentration-Dependent Mycobacterium tuberculosis Killing and Prevention of Resistance by Rifampin Antimicrobial Agents and Chemotherapy ·Tawanda Gumbo, Arnold Louie, Mark R. Deziel, Weiguo Liu, Linda M. Parsons, Max Salfinger, George L. Drusano	2007	276
4	The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis Respiratory Research ·Ákos Somoskövi, Linda M. Parsons, Max Salfinger	2001	261
5	Selection of a Moxifloxacin Dose That Suppresses Drug Resistance inMycobacterium tuberculosis,by Use of an In Vitro Pharmacodynamic Infection Model and Mathematical Modeling The Journal of Infectious Diseases ·Tawanda Gumbo, Arnold Louie, Mark R. Deziel, Linda M. Parsons, Max Salfinger, George L. Drusano	2004	248
6	Characterization of rifampin-resistance in pathogenic mycobacteria Antimicrobial Agents and Chemotherapy ·Diana L. Williams, C Waguespack, K. D. Eisenach, Jack T. Crawford, F. Portaels, Max Salfinger, Charles M. Nolan, Chiyoji Abe, V. Sticht-Groh, Thomas P. Gillis	1994	227
7	Rapid and Simple Approach for Identification of Mycobacterium tuberculosis Complex Isolates by PCR-Based Genomic Deletion Analysis Journal of Clinical Microbiology ·Linda M. Parsons, Roland Brosch, Stewart T. Cole, Ákos Somoskövi, A Loder, Gisela Bretzel, Dick van Soolingen, Yvonne M. Hale, Max Salfinger	2002	203
8	Use of the National Committee for Clinical Laboratory Standards Guidelines for Disk Diffusion Susceptibility Testing in New York State Laboratories Journal of Clinical Microbiology ·Julia A. Kiehlbauch, George E. Hannett, Max Salfinger, W A Archinal, Catherine Monserrat, Cynthia J. Carlyn	2000	198
9	Practical Guidance for Clinical Microbiology Laboratories: Mycobacteria Clinical Microbiology Reviews ·Betty A. Forbes, Geraldine S. Hall, Melissa B. Miller, Susan Novak, Marie‐Claire Rowlinson, Max Salfinger, Ákos Somoskövi, David M. Warshauer, Michael L. Wilson	2018	190
10	Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis Molecular Microbiology ·Michelle H. Larsen, Catherine Vilchèze, Laurent Kremer, Gurdyal S. Besra, Linda M. Parsons, Max Salfinger, Leonid Heifets, Manzour Hernando Hazbón, David Alland, James C. Sacchettini, William R. Jacobs	2002	149
11	Diagnostic performance of amplified Mycobacterium tuberculosis direct test with cerebrospinal fluid, other nonrespiratory, and respiratory specimens Journal of Clinical Microbiology ·G E Pfyffer, Patrick A. Kißling, E M Jahn, H M Welscher, Max Salfinger, Rainer Weber	1996	138
12	Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method Antimicrobial Agents and Chemotherapy ·Max Salfinger, Leonid Heifets	1988	113
13	Pseudoepidemic of Nontuberculous Mycobacteria due to a Contaminated Bronchoscope Cleaning Machine CHEST Journal ·Jacques Gubler, Max Salfinger, Alexander von Graevenitz	1992	105
14	Stability of DNA fingerprint pattern produced with IS6110 in strains of Mycobacterium tuberculosis Journal of Clinical Microbiology ·M. Donald Cave, Kathleen D. Eisenach, Gary L. Templeton, Max Salfinger, Gerald H. Mazurek, Joseph H. Bates, Jack T. Crawford	1994	104
15	Multicenter Laboratory Validation of Susceptibility Testing of Mycobacterium tuberculosis against Classical Second-Line and Newer Antimicrobial Drugs by Using the Radiometric BACTEC 460 Technique and the Proportion Method with Solid Media Journal of Clinical Microbiology ·Gaby E. Pfyffer, Donald A. Bonato, Adeleh Ebrahimzadeh, Wendy Gross, Jacqueline E. Hotaling, John Kornblum, A László, Glenn D. Roberts, Max Salfinger, Franziska Wittwer, Salman H. Siddiqi	1999	98
16	Molecular Characterization of Rifampin-Resistant Isolates of Mycobacterium tuberculosis from Hungary by DNA Sequencing and the Line Probe Assay Journal of Clinical Microbiology ·Zoltán Bártfai, Ákos Somoskövi, Csaba Ködmön, Nóra Szabó, Erzsébet Puskás, Lászlóné Kosztolányi, E Faragó, Judit Mester, Linda M. Parsons, Max Salfinger	2001	97
17	Mycobacteriosis due to Mycobacterium genavense in six pet birds Journal of Clinical Microbiology ·Richard K. Hoop, Erik C. Böttger, P. Ossent, Max Salfinger	1993	86
18	The new diagnostic mycobacteriology laboratory European Journal of Clinical Microbiology & Infectious Diseases ·Max Salfinger, G E Pfyffer	1994	85
19	Epidemiology and Clinical Significance of Nontuberculous Mycobacteria in Patients Negative for Human Immunodeficiency Virus in Switzerland Clinical Infectious Diseases ·Marc Debrunner, Max Salfinger, O Brändli, A. von Graevenitz	1992	81
20	Notes from the Field:Mycobacterium chimaeraContamination of Heater-Cooler Devices Used in Cardiac Surgery—United States MMWR Morbidity and Mortality Weekly Report ·Kiran M. Perkins, Adrian Lawsin, Nabeeh A. Hasan, Michael Strong, Alison Laufer Halpin, R Rodger, Heather Moulton-Meissner, Matthew B. Crist, Suzanne Schwartz, Julia Marders, Charles L. Daley, Max Salfinger, Joseph F. Perz	2016	78

About Max Salfinger

Max Salfinger is a scholar working on Infectious Diseases, Epidemiology, Microbiology, Small Animals and Molecular Medicine, having authored 113 papers that have together received 5.7k indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (87 papers), Tuberculosis Research and Epidemiology (73 papers), Infectious Diseases and Tuberculosis (16 papers), Infectious Diseases and Mycology (15 papers), Diagnosis and treatment of tuberculosis (10 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers), Bacterial Identification and Susceptibility Testing (7 papers) and Pneumonia and Respiratory Infections (6 papers). The work is most often cited by research in Infectious Diseases (4.3k citations), Epidemiology (4.1k citations), Molecular Medicine (470 citations), Small Animals (589 citations) and Microbiology (55 citations). Max Salfinger has collaborated with scholars based in United States, Switzerland and Hungary. Frequent co-authors include Linda M. Parsons, Ákos Somoskövi, David M. Warshauer, Tawanda Gumbo, Mark R. Deziel, Arnold Louie, Gerald H. Mazurek, Charles L. Daley, Leonid Heifets and Yvonne M. Hale. Their work appears in journals such as Journal of Clinical Microbiology, Clinical Infectious Diseases, Diagnostic Microbiology and Infectious Disease, European Journal of Clinical Microbiology & Infectious Diseases and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact